Imperva Stock Price, News & Analysis (NASDAQ:IMPV)

$40.20 -0.60 (-1.47 %)
(As of 11/18/2017 07:31 AM ET)
Previous Close$40.20
Today's Range$40.10 - $41.05
52-Week Range$35.45 - $52.40
Volume331,828 shs
Average Volume364,711 shs
Market Capitalization$1.36736 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.82

About Imperva (NASDAQ:IMPV)

Imperva logoImperva, Inc. provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company's products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services. Its Imperva SecureSphere provides database, file and Web application security across various physical and virtual systems in data centers, including in private, public and hybrid cloud computing environments. Its Imperva Incapsula product line provides cloud-based Website security, denial of service protection and performance solutions. Its Imperva Camouflage creates realistic, functional data for development, testing, and training by disguising sensitive information, while maintaining the characteristics of the original data.


Industry, Sector and Symbol:
  • Industry: IT Services & Consulting
  • Sub-Industry: Systems Software
  • Sector: Computer and Technology
  • Symbol: NASDAQ:IMPV
  • CUSIP: 45321L10
  • Web: www.imperva.com
Debt:
  • Current Ratio: 2.56%
  • Quick Ratio: 2.55%
Sales & Book Value:
  • Annual Sales: $264.45 million
  • Price / Sales: 5.17
  • Book Value: $8.78 per share
  • Price / Book: 4.58
Profitability:
  • Trailing EPS: $0.27
  • Net Income: ($70,270,000.00)
  • Net Margins: 3.04%
  • Return on Equity: -8.52%
  • Return on Assets: -4.99%
Misc:
  • Employees: 993
  • Outstanding Shares: 34,010,000
 

Frequently Asked Questions for Imperva (NASDAQ:IMPV)

What is Imperva's stock symbol?

Imperva trades on the NASDAQ under the ticker symbol "IMPV."

How were Imperva's earnings last quarter?

Imperva, Inc. (NASDAQ:IMPV) issued its quarterly earnings results on Wednesday, November, 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.22 by $0.11. The software maker had revenue of $83.89 million for the quarter, compared to analyst estimates of $83.79 million. Imperva had a negative return on equity of 8.52% and a net margin of 3.04%. The business's revenue was up 22.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.08 earnings per share. View Imperva's Earnings History.

What guidance has Imperva issued on next quarter's earnings?

Imperva issued an update on its fourth quarter earnings guidance on Wednesday, November, 8th. The company provided earnings per share (EPS) guidance of $0.24-0.29 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.25. The company issued revenue guidance of $89.2-92.2 million, compared to the consensus revenue estimate of $92.69 million.

Where is Imperva's stock going? Where will Imperva's stock price be in 2017?

15 Wall Street analysts have issued 1 year target prices for Imperva's shares. Their predictions range from $39.00 to $61.00. On average, they expect Imperva's stock price to reach $51.91 in the next twelve months. View Analyst Ratings for Imperva.

What are Wall Street analysts saying about Imperva stock?

Here are some recent quotes from research analysts about Imperva stock:

  • 1. According to Zacks Investment Research, "Imperva Inc. is engaged in the development of protection software and services for business applications and databases. The Company delivers innovative technology to give full audit accountability and separation of duties to meet regulatory compliance. It offers SecureSphere Data Security Suite to protect sensitive data from hackers and malicious insiders along with providing a fast and cost-effective route to regulatory compliance and establishes a repeatable process for data risk management. The Company's SecureSphere offers database security solutions to secure sensitive data stored in databases, File Security solutions to protect sensitive files on file servers, storage devices, content repositories, and meet regulatory compliance mandates and Web Application Security solutions to protect web applications from cyber attacks. Imperva Inc. is headquartered in Redwood Shores, California. " (10/24/2017)
  • 2. Evercore ISI analysts commented, "We believe that the quarter was in part helped by the deposition of Skyfence which carried annual operating expenses of ~$25M (and revenue of ~$1M). There is likely a tailwind to margins in 2Q from the deposition as well, despite the company’s ongoing plans to reinvest the savings in growth areas. Management guided to ~7% non-GAAP margins for F17 which compares favorably to consensus of ~5.6% going into the quarter. We continue to believe that the company is working to improve its business but has largely overcome the execution challenges that plagued results last year. We are encouraged by the high level of growth (+64.5% y/y in 1Q17) seen in the company’s subscription offerings which may be further helped by the introduction of FlexProtect which makes form factor (on-prem vs cloud) less relevant. This should offset concerns on the company’s on-premise WAF decline." (5/5/2017)

Who are some of Imperva's key competitors?

Who are Imperva's key executives?

Imperva's management team includes the folowing people:

  • Anthony J. Bettencourt, Chairman of the Board, Vice President - Customer Engagement (Age 56)
  • Christopher S. Hylen, President, Chief Executive Officer, Director (Age 56)
  • Aaron Kuan, Interim Chief Financial Officer (Age 46)
  • Tram T. Phi, Senior Vice President, General Counsel, Corporate Secretary (Age 46)
  • Brett Hooper, Senior Vice President - People (Age 53)
  • Sunil D. Nagdev, Senior Vice President and General Manager, Incapsula, Professional and Customer Services (Age 53)
  • Terry Ray, Chief Technology Officer
  • Amichai Shulman, Chief Scientific Officer (Age 47)
  • Michael D. Mooney, Chief Revenue Officer (Age 56)
  • Allan Roger Tessler, Lead Independent Director (Age 80)

Who owns Imperva stock?

Imperva's stock is owned by many different of retail and institutional investors. Top institutional investors include ELLIOTT ASSOCIATES, L.P. (6.70%), Eagle Asset Management Inc. (3.83%), JPMorgan Chase & Co. (3.24%), Alyeska Investment Group L.P. (2.67%), Emerald Advisers Inc. PA (1.94%) and Emerald Mutual Fund Advisers Trust (1.59%). Company insiders that own Imperva stock include Albert A Pimentel, Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Shlomo Kramer, Sunil D Nagdev, Terrence J Schmid and Tram T Phi. View Institutional Ownership Trends for Imperva.

Who sold Imperva stock? Who is selling Imperva stock?

Imperva's stock was sold by a variety of institutional investors in the last quarter, including Alpine Associates Management Inc., JPMorgan Chase & Co., Artemis Investment Management LLP, OxFORD Asset Management LLP, Dai Ichi Life Insurance Company Ltd, Fisher Asset Management LLC, Retirement Systems of Alabama and Dynamic Technology Lab Private Ltd. Company insiders that have sold Imperva company stock in the last year include Amichai Shulman, Anthony J Bettencourt, Mark E Kraynak, Michael D Mooney, Sunil D Nagdev and Terrence J Schmid. View Insider Buying and Selling for Imperva.

Who bought Imperva stock? Who is buying Imperva stock?

Imperva's stock was bought by a variety of institutional investors in the last quarter, including Alyeska Investment Group L.P., Caisse DE Depot ET Placement DU Quebec, American Century Companies Inc., Ameriprise Financial Inc., Emerald Advisers Inc. PA, OZ Management LP, Emerald Mutual Fund Advisers Trust and First Trust Advisors LP. View Insider Buying and Selling for Imperva.

How do I buy Imperva stock?

Shares of Imperva can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Imperva's stock price today?

One share of Imperva stock can currently be purchased for approximately $40.20.

How big of a company is Imperva?

Imperva has a market capitalization of $1.36736 billion and generates $264.45 million in revenue each year. The software maker earns ($70,270,000.00) in net income (profit) each year or $0.27 on an earnings per share basis. Imperva employs 993 workers across the globe.

How can I contact Imperva?

Imperva's mailing address is 3400 BRIDGE PARKWAY, REDWOOD SHORES CA, 94065. The software maker can be reached via phone at 650-345-9000 or via email at [email protected]


MarketBeat Community Rating for Imperva (NASDAQ IMPV)

Community Ranking:  3.4 out of 5 (star star star)
Outperform Votes:  549 (Vote Outperform)
Underperform Votes:  269 (Vote Underperform)
Total Votes:  818
MarketBeat's community ratings are surveys of what our community members think about Imperva and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Rating for Imperva (NASDAQ:IMPV)

  (How are Consensus Ratings Calculated?)
Ratings Breakdown: 1 Sell Rating, 6 Hold Ratings, 8 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Hold (Score: 2.47)
Consensus Price Target: $51.91 (29.13% upside)

Consensus Price Target History for Imperva (NASDAQ:IMPV)

Price Target History for Imperva (NASDAQ:IMPV)

Analysts' Ratings History for Imperva (NASDAQ:IMPV)

Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
11/9/2017Morgan StanleyReiterated RatingUnderweight -> Underweight$39.00N/AView Rating Details
11/9/2017Oppenheimer Holdings, Inc.Reiterated RatingBuy$55.00N/AView Rating Details
11/9/2017Stifel NicolausReiterated RatingHold -> Hold$50.00 -> $47.00N/AView Rating Details
11/8/2017Evercore ISIReiterated RatingBuy$56.00N/AView Rating Details
10/24/2017KeyCorpReiterated RatingHoldN/AView Rating Details
10/18/2017Royal Bank Of CanadaReiterated RatingBuy$49.00N/AView Rating Details
10/16/2017Piper Jaffray CompaniesDowngradeOverweight -> Neutral$42.00N/AView Rating Details
10/10/2017Imperial CapitalLower Price TargetOutperform$57.00 -> $50.00N/AView Rating Details
10/10/2017William BlairDowngradeOutperform -> Market PerformN/AView Rating Details
10/9/2017Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
7/28/2017Monness Crespi & HardtBoost Price TargetBuy$55.00 -> $57.00HighView Rating Details
7/13/2017StephensReiterated RatingOverweight$53.00 -> $61.00LowView Rating Details
6/7/2017Susquehanna Bancshares IncInitiated CoveragePositive -> Positive$60.00LowView Rating Details
3/22/2017DA DavidsonReiterated RatingBuy$55.00LowView Rating Details
2/9/2017BTIG ResearchInitiated CoverageNeutralN/AView Rating Details
11/4/2016NomuraReiterated RatingHold$37.50N/AView Rating Details
11/4/2016J P Morgan Chase & CoReiterated RatingHold$46.00N/AView Rating Details
11/4/2016Needham & Company LLCUpgradeHold -> Buy$64.00 -> $43.00N/AView Rating Details
11/4/2016MacquarieUpgradeNeutral -> OutperformN/AView Rating Details
10/22/2016Buckingham ResearchReiterated RatingNeutral$45.00N/AView Rating Details
10/15/2016Deutsche Bank AGReiterated RatingHoldN/AView Rating Details
9/25/2016JMP SecuritiesReiterated RatingOutperform$50.00 -> $56.00N/AView Rating Details
9/13/2016WunderlichInitiated CoverageHold$50.00N/AView Rating Details
8/30/2016Pacific CrestDowngradeOverweight -> Sector Weight$47.00 -> $30.00N/AView Rating Details
2/4/2016Topeka Capital MarketsLower Price TargetBuy$80.00 -> $65.00N/AView Rating Details
1/21/2016Northland SecuritiesInitiated CoverageOutperform$77.00N/AView Rating Details
1/11/2016GuggenheimUpgradeNeutral -> BuyN/AView Rating Details
(Data available from 11/19/2015 forward)

Earnings

Earnings History and Estimates Chart for Imperva (NASDAQ:IMPV)

Earnings by Quarter for Imperva (NASDAQ:IMPV)

Earnings History by Quarter for Imperva (NASDAQ IMPV)

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/8/2017Q3 2017$0.22$0.33$83.79 million$83.89 millionViewN/AView Earnings Details
7/27/2017Q2 2017$0.05($0.10)$74.30 million$74.44 millionViewN/AView Earnings Details
5/4/2017Q1 2017($0.62)($0.29)$68.16 million$72.31 millionViewListenView Earnings Details
2/8/2017Q416$0.03$0.32$70.22 million$78.40 millionViewListenView Earnings Details
11/3/2016Q316($0.16)$0.08$63.10 million$68.40 millionViewListenView Earnings Details
8/4/2016Q216($0.04)($0.23)$66.06 million$57.87 millionViewListenView Earnings Details
5/5/2016Q116($0.28)($0.25)$59.65 million$59.80 millionViewListenView Earnings Details
2/3/2016Q415$0.15$0.20$68.11 million$72.70 millionViewListenView Earnings Details
10/29/2015Q3($0.05)$0.19$56.52 million$63.30 millionViewListenView Earnings Details
8/6/2015Q215($0.21)($0.08)$48.40 million$53.50 millionViewListenView Earnings Details
5/7/2015Q115($0.38)($0.26)$40.50 million$44.80 millionViewListenView Earnings Details
2/5/2015Q414($0.04)($0.04)$49.80 million$51.40 millionViewListenView Earnings Details
10/30/2014Q314($0.63)($0.51)$40.00 million$42.70 millionViewListenView Earnings Details
5/1/2014Q114($0.41)($0.36)$31.73 million$31.50 millionViewListenView Earnings Details
2/6/2014Q413$0.11$0.12$41.63 million$42.70 millionViewListenView Earnings Details
11/5/2013Q313($0.05)($0.01)$34.43 million$35.10 millionViewListenView Earnings Details
8/7/2013Q2 2013($0.05)($0.10)$31.38 million$31.30 millionViewListenView Earnings Details
5/2/2013Q1 2013($0.10)($0.13)$27.49 million$28.60 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.02$0.06$29.91 million$31.80 millionViewListenView Earnings Details
8/9/2012($0.05)($0.02)ViewN/AView Earnings Details
5/3/2012($0.13)($0.12)ViewN/AView Earnings Details
2/9/2012($0.15)($0.05)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Imperva (NASDAQ:IMPV)
2017 EPS Consensus Estimate: ($1.83)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.75)($0.75)($0.75)
Q2 20171($0.55)($0.55)($0.55)
Q3 20171($0.38)($0.38)($0.38)
Q4 20171($0.15)($0.15)($0.15)
Q1 20181($0.60)($0.60)($0.60)
Q2 20181($0.51)($0.51)($0.51)
Q3 20181($0.50)($0.50)($0.50)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Imperva (NASDAQ:IMPV)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Imperva (NASDAQ IMPV)

Insider Ownership Percentage: 1.90%
Institutional Ownership Percentage: 98.33%
Insider Trades by Quarter for Imperva (NASDAQ:IMPV)
Institutional Ownership by Quarter for Imperva (NASDAQ:IMPV)

Insider Trades by Quarter for Imperva (NASDAQ IMPV)

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/24/2017Anthony J BettencourtDirectorSell99,598$43.59$4,341,476.82View SEC Filing  
5/16/2017Sunil D NagdevSVPSell4,857$49.00$237,993.00View SEC Filing  
5/15/2017Amichai ShulmanInsiderSell3,089$48.70$150,434.30View SEC Filing  
5/10/2017Michael D MooneyCROSell52,356$47.51$2,487,433.56View SEC Filing  
4/17/2017Amichai ShulmanInsiderSell3,085$41.97$129,477.45View SEC Filing  
3/15/2017Amichai ShulmanInsiderSell3,085$41.85$129,107.25View SEC Filing  
2/28/2017Mark E KraynakSVPSell45,314$41.63$1,886,421.82View SEC Filing  
2/21/2017Anthony J BettencourtChairmanSell84,863$45.55$3,865,509.65View SEC Filing  
2/21/2017Terrence J SchmidCFOSell4,500$45.53$204,885.00View SEC Filing  
2/16/2017Mark E KraynakSVPSell1,731$46.10$79,799.10View SEC Filing  
2/15/2017Amichai ShulmanInsiderSell3,085$45.91$141,632.35View SEC Filing  
1/17/2017Amichai ShulmanCTOSell3,085$40.60$125,251.00View SEC Filing  
12/21/2016Amichai ShulmanInsiderSell3,085$40.00$123,400.00View SEC Filing  
11/16/2016Mark E KraynakSVPSell3,332$40.16$133,813.12View SEC Filing  
11/15/2016Amichai ShulmanInsiderSell3,085$40.10$123,708.50View SEC Filing  
10/17/2016Amichai ShulmanInsiderSell3,085$48.57$149,838.45View SEC Filing  
10/3/2016Amichai ShulmanInsiderSell938$53.27$49,967.26View SEC Filing  
9/23/2016Amichai ShulmanInsiderSell937$51.00$47,787.00View SEC Filing  
9/23/2016Mark E. KraynakSVPSell5,582$51.00$284,682.00View SEC Filing  
9/15/2016Amichai ShulmanInsiderSell3,085$44.30$136,665.50View SEC Filing  
8/16/2016Mark E KraynakSVPSell2,614$47.73$124,766.22View SEC Filing  
8/15/2016Amichai ShulmanInsiderSell3,085$46.87$144,593.95View SEC Filing  
7/27/2016Amichai ShulmanInsiderSell3,085$46.28$142,773.80View SEC Filing  
7/26/2016Mark E KraynakSVPSell2,967$46.15$136,927.05View SEC Filing  
6/23/2016Shlomo KramerMajor ShareholderSell75,000$45.12$3,384,000.00View SEC Filing  
6/20/2016Shlomo KramerMajor ShareholderSell75,000$40.24$3,018,000.00View SEC Filing  
5/31/2016Terrence J SchmidCFOSell5,000$37.66$188,300.00View SEC Filing  
5/25/2016Anthony J BettencourtCEOSell50,000$36.15$1,807,500.00View SEC Filing  
5/19/2016Shlomo KramerMajor ShareholderSell50,000$34.20$1,710,000.00View SEC Filing  
5/17/2016Shlomo KramerMajor ShareholderSell75,000$33.95$2,546,250.00View SEC Filing  
5/16/2016Terrence J SchmidCFOSell7,000$33.99$237,930.00View SEC Filing  
5/12/2016Shlomo KramerMajor ShareholderSell75,000$34.16$2,562,000.00View SEC Filing  
3/31/2016Mark E. KraynakSVPSell2,758$50.00$137,900.00View SEC Filing  
3/1/2016Amichai ShulmanCTOSell3,000$45.25$135,750.00View SEC Filing  
2/24/2016Terrence J SchmidCFOSell6,500$41.82$271,830.00View SEC Filing  
2/17/2016Mark E KraynakSVPSell2,758$40.04$110,430.32View SEC Filing  
2/8/2016Albert A PimentelDirectorBuy5,000$38.93$194,650.00View SEC Filing  
2/8/2016Amichai ShulmanCTOSell4,150$38.12$158,198.00View SEC Filing  
2/1/2016Amichai ShulmanCTOSell3,000$50.49$151,470.00View SEC Filing  
1/4/2016Amichai ShulmanCTOSell5,812$60.36$350,812.32View SEC Filing  
12/1/2015Amichai ShulmanCTOSell3,000$74.22$222,660.00View SEC Filing  
11/19/2015Mark E. KraynakinsiderSell10,000$75.00$750,000.00View SEC Filing  
11/19/2015Tram T. PhiVPSell1,244$73.26$91,135.44View SEC Filing  
11/16/2015Anthony J. BettencourtCEOSell50,000$69.33$3,466,500.00View SEC Filing  
11/16/2015Mark E. KraynakinsiderSell3,789$68.73$260,417.97View SEC Filing  
11/12/2015Shlomo KramerMajor ShareholderSell100,000$71.65$7,165,000.00View SEC Filing  
11/6/2015Shlomo KramerMajor ShareholderSell50,000$72.14$3,607,000.00View SEC Filing  
11/4/2015Shlomo KramerMajor ShareholderSell25,000$72.05$1,801,250.00View SEC Filing  
11/4/2015Terrence J. SchmidCFOSell938$71.14$66,729.32View SEC Filing  
11/3/2015Shlomo KramerMajor ShareholderSell25,000$72.55$1,813,750.00View SEC Filing  
10/1/2015Amichai ShulmanCTOSell2,813$65.00$182,845.00View SEC Filing  
8/31/2015Terrence J. SchmidCFOSell1,595$61.56$98,188.20View SEC Filing  
8/17/2015Mark E KraynakInsiderSell1,520$71.42$108,558.40View SEC Filing  
7/23/2015Amichai ShulmanCTOSell9,000$70.00$630,000.00View SEC Filing  
5/11/2015Amichai ShulmanCTOSell10,313$51.09$526,891.17View SEC Filing  
5/11/2015Mark E KraynakInsiderSell4,000$55.00$220,000.00View SEC Filing  
4/20/2015Mark E KraynakInsiderSell3,000$47.53$142,590.00View SEC Filing  
1/20/2015Mark E KraynakInsiderSell3,000$44.60$133,800.00View SEC Filing  
1/8/2015Amichai ShulmanCTOSell1,875$50.00$93,750.00View SEC Filing  
12/16/2014Amichai ShulmanCTOSell9,492$50.00$474,600.00View SEC Filing  
12/15/2014Amichai ShulmanCTOSell11,133$50.00$556,650.00View SEC Filing  
12/1/2014Amichai ShulmanCTOSell5,000$42.44$212,200.00View SEC Filing  
11/28/2014Yaniv ShayaVPSell2,512$44.00$110,528.00View SEC Filing  
11/20/2014Mark E KraynakInsiderSell6,140$42.00$257,880.00View SEC Filing  
11/14/2014Yaniv ShayaVPSell20,938$44.52$932,159.76View SEC Filing  
11/13/2014Mark E KraynakInsiderSell2,000$45.00$90,000.00View SEC Filing  
11/11/2014Tram T PhiVPSell10,076$43.50$438,306.00View SEC Filing  
11/4/2014Terrence J SchmidCFOSell20,000$40.73$814,600.00View SEC Filing  
11/3/2014Amichai ShulmanCTOSell5,000$41.09$205,450.00View SEC Filing  
10/31/2014Amichai ShulmanCTOSell7,500$36.56$274,200.00View SEC Filing  
10/31/2014Mark E KraynakInsiderSell2,000$36.56$73,120.00View SEC Filing  
10/6/2014Amichai ShulmanCTOSell2,500$30.00$75,000.00View SEC Filing  
9/2/2014Amichai ShulmanCTOSell5,000$30.00$150,000.00View SEC Filing  
8/21/2014Terrence J SchmidCFOSell15,000$29.07$436,050.00View SEC Filing  
5/23/2014Ralph PisaniVPSell8,613$21.31$183,543.03View SEC Filing  
5/21/2014Terrence SchmidCFOSell15,000$21.26$318,900.00View SEC Filing  
4/7/2014Shlomo KramerCEOSell60,000$50.53$3,031,800.00View SEC Filing  
4/2/2014Shlomo KramerCEOSell40,000$55.67$2,226,800.00View SEC Filing  
1/8/2014Shlomo KramerCEOSell20,000$50.10$1,002,000.00View SEC Filing  
1/7/2014Shlomo KramerCEOSell40,000$49.99$1,999,600.00View SEC Filing  
1/3/2014Shlomo KramerCEOSell40,000$48.31$1,932,400.00View SEC Filing  
1/2/2014Amichai ShulmanCTOSell22,875$47.68$1,090,680.00View SEC Filing  
12/17/2013Amichai ShulmanCTOSell10,090$45.00$454,050.00View SEC Filing  
12/2/2013Amichai ShulmanCTOSell12,410$44.13$547,653.30View SEC Filing  
11/26/2013Yaniv ShayaVPSell5,243$43.92$230,272.56View SEC Filing  
11/21/2013Jason ForgetSVPSell8,558$38.98$333,590.84View SEC Filing  
11/21/2013Terrence SchmidCFOSell11,100$40.26$446,886.00View SEC Filing  
11/21/2013Tram PhiVPSell6,646$39.50$262,517.00View SEC Filing  
11/19/2013Mark KraynakVPSell3,190$37.80$120,582.00View SEC Filing  
8/29/2013Yaniv ShayaVPSell4,375$48.00$210,000.00View SEC Filing  
8/26/2013Jason ForgetSVPSell2,500$47.50$118,750.00View SEC Filing  
8/26/2013Yaniv ShayaVPSell5,000$47.71$238,550.00View SEC Filing  
8/23/2013Terrence SchmidCFOSell2,539$47.20$119,840.80View SEC Filing  
8/21/2013Jason ForgetSVPSell2,500$47.00$117,500.00View SEC Filing  
8/20/2013Terrence SchmidCFOSell10,461$47.03$491,980.83View SEC Filing  
8/16/2013Jason ForgetSVPSell2,062$47.00$96,914.00View SEC Filing  
8/14/2013Tram PhiVPSell5,000$46.00$230,000.00View SEC Filing  
8/13/2013Jason ForgetSVPSell2,000$45.01$90,020.00View SEC Filing  
8/13/2013Mark KraynakVPSell10,000$44.41$444,100.00View SEC Filing  
8/5/2013Amichai ShulmanCTOSell1,086$52.58$57,101.88View SEC Filing  
8/2/2013Amichai ShulmanCTOSell46,140$51.87$2,393,281.80View SEC Filing  
7/3/2013Amichai ShulmanCTOSell3,222$45.21$145,666.62View SEC Filing  
7/1/2013Amichai ShulmanCTOSell16,778$44.94$754,003.32View SEC Filing  
6/3/2013Amichai ShulmanCTOSell20,000$39.49$789,800.00View SEC Filing  
5/30/2013Amichai ShulmanCTOSell10,000$39.93$399,300.00View SEC Filing  
5/30/2013Yaniv ShayaVPSell4,375$40.40$176,750.00View SEC Filing  
5/29/2013Amichai ShulmanCTOSell20,000$39.96$799,200.00View SEC Filing  
5/28/2013Tram T PhiVPSell5,000$40.25$201,250.00View SEC Filing  
5/24/2013Yaniv ShayaVPSell2,250$40.00$90,000.00View SEC Filing  
5/14/2013Yaniv ShayaVPSell10,000$39.00$390,000.00View SEC Filing  
5/13/2013Albert A PimentelDirectorSell10,000$37.93$379,300.00View SEC Filing  
5/13/2013Ralph PisaniVPSell5,000$38.46$192,300.00View SEC Filing  
5/13/2013Terrence J SchmidCFOSell13,000$37.75$490,750.00View SEC Filing  
5/8/2013Jason ForgetSVPSell4,063$37.31$151,590.53View SEC Filing  
3/26/2013Amichai ShulmanCTOSell20,000$38.30$766,000.00View SEC Filing  
2/26/2013Amichai ShulmanCTOSell20,000$36.05$721,000.00View SEC Filing  
12/28/2012Amichai ShulmanCTOSell10,000$31.01$310,100.00View SEC Filing  
12/27/2012Amichai ShulmanCTOSell20,000$30.98$619,600.00View SEC Filing  
12/5/2012Michael BoodaeiDirectorSell30,000$31.48$944,400.00View SEC Filing  
11/27/2012Amichai ShulmanCTOSell20,000$29.06$581,200.00View SEC Filing  
11/7/2012James R TolonenDirectorBuy5,000$31.17$155,850.00View SEC Filing  
11/1/2012Amichai ShulmanCTOSell20,000$31.71$634,200.00View SEC Filing  
10/4/2012Michael BoodaeiDirectorSell30,000$34.03$1,020,900.00View SEC Filing  
9/5/2012Michael BoodaeiDirectorSell20,000$30.35$607,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Imperva (NASDAQ IMPV)

Source:

Social Media

Financials

Chart

Imperva (NASDAQ IMPV) Chart for Sunday, November, 19, 2017
Loading chart…

This page was last updated on 11/19/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.